|Articles|November 1, 2006
Supplements and Featured Publications
- New Treatment Strategies for Type 2 Diabetes: Role of the Thiazolidinediones
- Volume 12
- Issue 14 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 19 years ago
Case Studyover 19 years ago
CME/CE Quizover 19 years ago
Health Outcomes Beyond Glucose Controlover 19 years ago
Introductionover 19 years ago
Oral Combination Therapy with Thiazolidinediones in Type 2 DiabetesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
